ArticleActa neuropathologica communications2026
Translation of expanded CGG repeats in LRP12 associated oculopharyngodistal myopathy.
Article in Acta neuropathologica communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Population-scale detection of methylation outliers from long-read genome sequencing.medRxiv : the preprint server for health sciences · 2026Article
- Dominantly inherited muscle disorders: understanding their complexity and exploring therapeutic approaches.Disease models & mechanisms · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Oculopharyngodistal myopathy (OPDM) is characterized by ptosis, ophthalmoparesis, dysphagia, and distal weakness. Myopathological features include rimmed vacuoles and intranuclear inclusions. OPDM is associated with a pathogenic CGG repeat expansions in the 5'UTR of LRP12, NOTCH2NLC, GIPC1, RILPL1 and ABCD3. Translation of the repeat in the glycine reading frame has been demonstrated for expansions in FMR1, NOTCH2NLC and GIPC1. To assess for a similar phenomenon with LRP12, we expressed normal or expanded CGG repeats in the context of the 5'UTR of LRP12, upstream of a green fluorescent protein (GFP) in the three repeat reading frames. Repeat dependent translation occurs exclusively in the glycine reading frame. However, unlike other CGG repeat disorders, there is no proximal AUG, or near-AUG cognate initiated polyglycine (polyG) open reading frame in LRP12. Instead, our results support a model in which repeat-associated non-AUG (RAN) mediated polyG translation may initiate within the arginine reading frame and then undergo a + 1 translational frameshift into the glycine reading frame. LRP12-associated polyG products form intranuclear SQSTM1/ubiquitin positive inclusions that are cytotoxic and alter the nuclear lamina architecture in transfected cells. While FMR1-associated polyG inclusions are cytosolic, LRP12-associated polyG inclusions are nuclear in transfected skeletal muscle. LRP12 expansion carrier iPSC derived myotubes exhibit SQSTM1 positive intra- and peri- nuclear inclusions when compared with control patient myotubes, suggesting that polyG expression can occur in patients. Together, these findings provide evidence of RAN translation and polyG-toxicity in LRP12-associated OPDM pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.